Greg Harmston
Family Medicine · Galena, ILNPI 1679549877
Payments from drug & device makers
Across 206 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$974
- Johnson & Johnson$469
- Amgen$447
- Boehringer Ingelheim$282
- Merck$275
- Bayer$271
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,78997%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $974 |
| Johnson & Johnson | 27 | $469 |
| Amgen | 22 | $447 |
| Boehringer Ingelheim | 17 | $282 |
| Merck | 14 | $275 |
| Bayer | 15 | $271 |
| Novo Nordisk | 15 | $247 |
| Lilly USA, LLC | 16 | $238 |
| Pfizer | 11 | $194 |
| Exact Sciences | 5 | $105 |
| Astellas Pharma US Inc | 1 | $100 |
| Sanofi-aventis U.S. LLC | 3 | $68 |
| Mylan Specialty L.p. | 4 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Novartis | 3 | $43 |
| Dexcom, Inc. | 1 | $19 |
| AbbVie | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| BD | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$102
How this compares
$3,889 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $81,974 |
| MounjaroTirzepatide | 69 | $79,748 |
| OrenciaAbatacept | 13 | $65,833 |
| RybelsusSemaglutide | 31 | $54,439 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 12 | $48,022 |
| JardianceEmpagliflozin | 50 | $45,791 |
| EliquisApixaban | 49 | $37,957 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $20,286 |
| TrulicityDulaglutide | 18 | $18,622 |
| FarxigaDapagliflozin Propanediol | 11 | $18,138 |
| XareltoRivaroxaban | 21 | $16,672 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $13,515 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $9,838 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $8,893 |
| Varenicline Tartrate | 26 | $7,824 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $247 | $136,413102 claims |
| Lilly USA, LLCMounjaro, Trulicity | $238 | $98,37087 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $282 | $50,79561 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $974 | $47,31778 claims |
| PfizerEliquis | $194 | $37,95749 claims |
| Johnson & JohnsonXarelto | $469 | $16,67221 claims |
| AbbVieSynthroid | $16 | $1,44226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Galena
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.